| Forbes As part of it’s raised bid for Allergan, Valeant Pharmaceuticals is offering a contingent value right, or CVR, for Allergan’s experimental drug for wet age-related macular degeneration(AMD), DARPin. The idea is that Valeant would set up a separate … Valeant Increases Takeover Offer for AllerganWall Street Journal |
Source: Wet Macular Degeneration News From Google News
Zennie Abraham | Zennie Abraham or “Zennie62” is the founder of Zennie62Media which consists of zennie62blog.com and a multimedia blog news aggregator and video network, and 78-blog network, with social media and content development services and consulting. Zennie is a pioneer video blogger, YouTube Partner, social media practitioner, game developer, and pundit. Note: news aggregator content does not reflect the personal views of Mr. Abraham.